SubQ vs IM Peptide Injections

Subcutaneous or intramuscular? For most peptides the answer is simple: subcutaneous. But there are nuances worth understanding.

Subcutaneous (subQ)

Standard for peptides. Needle goes into a skin fold (abdomen, thigh, shoulder) at 45-90°. Insulin needles 29-31G, nearly painless. Absorption is slower than IM, but for peptides this is a plus: smoother delivery, predictable pharmacokinetics.

All PEPTEX peptides are designed for subcutaneous use: [[Tirzepatide|10]], [[BPC-157|22]], ipamorelin, tesamorelin, NAD+, and all pen formats.

Intramuscular (IM)

Needle goes deeper, into the muscle (deltoid, glute, quad). Faster absorption. Used by some for GH secretagogues wanting a sharper peak. But for most peptides the efficacy difference is minimal and the discomfort is greater.

BPC-157: special case

BPC-157 is often recommended near the problem area. If it's a tendon or joint, subQ nearby. If the problem is deep in a muscle, some use IM injection into that muscle. Local administration provides higher peptide concentration exactly where repair is needed.

Bottom line

For 95% of cases: subcutaneous. Simpler, less painful, predictable. IM only for specific BPC-157 situations with deep muscle injuries.

Questions about injection technique? Reach out to us.

This article is for educational purposes. Peptides are intended for research use. Consult a healthcare professional before starting any protocol.